tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Zenas Biopharma Inc

ZBIO
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
28.010USD
+0.370+1.34%
์ข…๊ฐ€ย 11-13 16:00๏ผˆET๏ผ‰
1.83B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Zenas Biopharma Inc ์ •๋ณด ํšŒ์‚ฌ

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company focused on the development and commercialization of transformative therapies for patients with autoimmune diseases. The Company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company is developing obexelimab as a potential immunology and inflammation (I&I) franchise for patients in several autoimmune diseases. The first three indications it is pursuing include immunoglobulin G4-related disease (IgG4-RD), relapsing multiple sclerosis (RMS) and systemic lupus erythematosus (SLE). Its other programs include ZB002 (an anti-TNFฮฑ monoclonal antibody), ZB004 (a CTLA-4-Ig fusion), and ZB001 and related programs. ZB002 is a recombinant human monoclonal antibody directed at human TNFฮฑ.

Zenas Biopharma Inc ํ”„๋กœํ•„

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ ZBIO
ํšŒ์‚ฌ ์ด๋ฆ„Zenas Biopharma Inc
์ƒ์žฅ์ผSep 13, 2024
CEOMoulder (Leon O)
์ง์› ์ˆ˜130
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒSep 13
์ฃผ์†Œ1000 Winter St, Suite 1200
๋„์‹œWALTHAM
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ02451
์ „ํ™”18572712954
์›น์‚ฌ์ดํŠธhttps://zenasbio.com/
์ข…๋ชฉ ์ฝ”๋“œ ZBIO
์ƒ์žฅ์ผSep 13, 2024
CEOMoulder (Leon O)

Zenas Biopharma Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. James P. (Jim) Boylan
Mr. James P. (Jim) Boylan
Lead Independent Director
Lead Independent Director
--
--
Ms. Christy Oliger
Ms. Christy Oliger
Independent Director
Independent Director
--
--
Ms. Patricia Allen
Ms. Patricia Allen
Independent Director
Independent Director
--
--
Mr. Leon O. Moulder, Jr.
Mr. Leon O. Moulder, Jr.
Founder, Chairman of the Board of Director, Chief Executive Officer
Founder, Chairman of the Board of Director, Chief Executive Officer
--
--
Ms. Christy Oliger
Ms. Christy Oliger
Independent Director
Independent Director
--
--
Mr. Orlando Oliveira
Mr. Orlando Oliveira
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Jennifer Fox
Ms. Jennifer Fox
Chief Business Officer, Chief Financial Officer
Chief Business Officer, Chief Financial Officer
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. James P. (Jim) Boylan
Mr. James P. (Jim) Boylan
Lead Independent Director
Lead Independent Director
--
--
Ms. Christy Oliger
Ms. Christy Oliger
Independent Director
Independent Director
--
--
Ms. Patricia Allen
Ms. Patricia Allen
Independent Director
Independent Director
--
--

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Zenas Biopharma Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
Zenas Biopharma Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค: Mr. Joseph L. (Joe) Farmer, J.D.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ